The Cell and Gene Therapy Catapult (CGT Catapult) is dedicated to advancing the cell and gene therapy industry by providing a comprehensive suite of technologies and expertise aimed at overcoming challenges in the development and commercialization of Advanced Therapy Medicinal Products (ATMPs). Their capabilities encompass early-stage development, manufacturing innovation, regulatory affairs, and health economics, all designed to enhance the safety, efficacy, scalability, and affordability of cell and gene therapies. The organization employs a Quality by Design (QbD) approach to ensure that processes are robust and compliant with Good Manufacturing Practice (GMP) standards, facilitating the seamless transition of therapies from the lab to clinical settings.

CGT Catapult's technological offerings include advanced bioprocessing solutions for viral vectors, stem cell expansion, and cell engineering. They focus on developing innovative manufacturing processes, such as intensified perfusion techniques for producing Adeno-Associated Virus (AAV) vectors, which are crucial for gene therapies targeting various conditions. Their expertise extends to cryopreservation methods, bioprocess control, and automation, ensuring that therapies maintain their viability and quality throughout production. By leveraging data analytics and digital technologies, CGT Catapult aims to optimize manufacturing processes and enhance the overall efficiency of ATMP development, ultimately contributing to the growth and success of the cell and gene therapy sector in the UK.

United Kingdom

The Offshore Renewable Energy (ORE) Catapult forms part of an elite network of eight technology and innovation centres established and overseen by Innovate UK, which represents a £1bn public and private sector investment over the next five years.

ORE Catapult is the UK's flagship technology innovation and research centre for offshore wind, wave and tidal energy. We deliver prioritised research underpinned by world-class test and demonstration facilities, collaborating with industry, academia and Government to reduce the cost of offshore renewable energy and create UK economic benefit.

Cell and Gene Therapy Catapult

Company Details